- In addition to starting a new R&D trial with Rutgers University, Bee Vectoring Technologies (BEE) has secured sales commitments from two New Jersey berry growers
- The study will evaluate the efficacy of BVT’s proprietary fungicide, Vectorite with CR-7
- BVT is focused on the control of pests and enhancement of crops
- Bee Vectoring Technologies International (BEE) is down 2.63 per cent and is trading at $0.37 per share
Bee Vectoring Technologies (BEE) is starting an R&D trial with Rutgers University and has secured sales commitments from two New Jersey berry growers.
The trial with Rutgers University’s Agricultural Research and Extension Center is testing blueberry crops in four New Jersey locations.
The study will evaluate the efficacy of BVT’s proprietary fungicide, Vectorite with CR-7, and apply it with bee vectoring technology against crop disease under local conditions.
Everett Hendrixon, Midwest and Eastern US territory manager at Bee Vectoring Technologies, commented,
“When it comes to industry influence, Rutgers is the absolute leader for agriculture in New Jersey. Growers look to and trust them, so this trial with such an authoritative body is a strong first step in our expansion in this important market.”
He added,
“We’ve had some growers in other states use our system for a season and not use it for the next, then return after seeing high disease pressure and reduced yield. Compelling research from experts like Rutgers will help mitigate this uneven cycle.”
The blueberry blooming period started in mid-April, and the New Jersey growers are already using BVT’s natural precision agriculture system on about 20 of 550 acres under production.
Ian Collinson, sales manager at Bee Vectoring Technologies, commented,
“The Rutgers trial and the grower commitments align with our 2021 commercialization objectives.”
“We have real momentum going in the US, and anticipate it will keep building in coming seasons,” he added.
BVT is focused on the control of pests and enhancement of crops and ornamentals by biological controls in a variety of application processes.
Bee Vectoring Technologies International (BEE) is down 2.63 per cent and is trading at $0.37 per share as of 12:36 pm ET.
